医学
肾细胞癌
内科学
靶向治疗
多元分析
中性粒细胞与淋巴细胞比率
肿瘤科
中性粒细胞绝对计数
淋巴细胞
胃肠病学
癌症
毒性
中性粒细胞减少症
作者
Nobuyuki Tanaka,Ryuichi Mizuno,Yota Yasumizu,Keiichi Ito,Suguru Shirotake,Ayako Masunaga,Y. Ito,Yasumasa Miyazaki,Masaru Hagiwara,Kent Kanao,Shuji Mikami,Ken Nakagawa,Tetsuo Momma,Takeshi Masuda,Tomohiko Asano,Masafumi Oyama,Mototsugu Oya
标识
DOI:10.1016/j.urolonc.2016.10.001
摘要
The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk model has been designed for prognostification in patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy. One factor is neutrophil count; however, increasing evidence has suggested the superiority of neutrophil-to-lymphocyte ratio (NLR) for predicting outcome. In this study, we evaluate the prognostic effect of NLR levels on patients with mRCC treated with targeted therapy, and then we compare the predictive accuracy of the IMDC risk model and its modified one by using NLR, instead of neutrophil count. A total of 277 patients are included for the analysis. All patients underwent targeted therapies and associated outcome are assessed using multivariate analysis. Pretreatment NLR levels are elevated in 30.3% and 23.1% of patients in the first-line and subsequent second-line setting, respectively. Kaplan-Meier curves reveal that elevated pretreatment NLR is significantly associated with poor overall survival (OS) since first-line (P<0.001) and second-line targeted therapy administration (P<0.001). Also, multivariate analyses show that elevated pretreatment NLR is an independent predictor for poor OS since first-line and second-line targeted therapy administration. The addition of NLR to the IMDC risk model, instead of neutrophil count, significantly improves the predictive accuracy for OS, and estimated gain is 1.7% and 6.2% in first-line and second-line targeted therapy, respectively. Changes in NLR levels could be predictive for prognosis in patients with mRCC treated with first-line and second-line targeted therapy. The addition of NLR significantly improves the predictive accuracy of the IMDC risk model in the first-line and subsequent second-line setting.
科研通智能强力驱动
Strongly Powered by AbleSci AI